Normal view MARC view ISBD view

[Increased vitamin D utilization under penicillin administration in experimental rickets in rat]. [electronic resource]

By:

REKLING, E

Contributor(s):

Producer: 20030501Description: 300-1 p. digitalISSN:

0029-1420

Subject(s):

In: Nordisk medicin vol. 51

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

821 Standard methods to measure HIV drug concentrations.
by Luber, A D
822 Mitochondrial dysfunction and the role of the non-specialist laboratory.
by Hancock, Maggie R
823 A tight-binding mode of inhibition is essential for anti-human immunodeficiency virus type 1 virucidal activity of nonnucleoside reverse transcriptase inhibitors.
by Motakis, Dimitrios
824 All kidding aside with the use of lamivudine in children with chronic hepatitis B.
by Zucker, Stephen D
825 HIV-treatment guidelines.
826 Synthesis and evaluation of analogs of Efavirenz (SUSTIVA) as HIV-1 reverse transcriptase inhibitors.
by Patel, M
827 [Current HIV therapy and its clinical problems].
by Oka, S
828 Serum hyaluronic acid during lamivudine treatment in chronic hepatitis B.
by Grzeszczuk, A
829 Should non-nucleoside reverse transcriptase inhibitors be combined?
by Kappelhoff, Bregt S
830 The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide A.
by Auwerx, Joeri
831 Top stories of 2004. To 3TC or not to 3TC?
by Albrecht, Helmut
832 Report from the 12th Retrovirus Conference. Hepatitis.
by Albrecht, Helmut
833 Study of efavirenz over 96 weeks shows durability, efficacious regimen. Results from 48-96 weeks essentially same.
834 New HIV-1 reverse transcriptase inhibitors based on a tricyclic benzothiophene scaffold: synthesis, resolution, and inhibitory activity.
by Krajewski, Krzysztof
835 Fanconi syndrome associated with use of tenofovir in HIV-infected patients: a case report and review of the literature.
by Quimby, David
836 FDA approves generic AZT for U.S. market.
by O'Rourke, Matthew
837 Tenofovir trials raise ethical issues.
by Mills, Edward
838 Symptomatic hyperlactataemia and lactic acidosis in the era of highly active antiretroviral therapy.
by Eshun-Wilson, Ingrid
839 FTC (Emtriva) approved.
by James, John S
840 Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Resistance rates in treatment-naive patients.
by Sax, P E